Vaccinia virus-mediated high level expression and single step purification of recombinant Jak2 protein

被引:8
作者
Ma, XY [1 ]
Sayeski, PP [1 ]
机构
[1] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA
关键词
D O I
10.1016/j.pep.2004.02.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Jak2 functions as a non-receptor tyrosine kinase and has been linked to pathologies such as cancer and cardiovascular disease. Because of this, many studies have tried to better understand its function. Unfortunately, very little information is known about its catalytic or biochemical properties as purification of significant amounts of functional Jak2 protein has been exceedingly difficult. Here, Jak2 was expressed in BSC-40 cells using a vaccinia virus-mediated expression system. Significant amounts (similar to 10 mug) of Jak2 protein were expressed from a single 100-mm cell culture dish. The protein was first harvested using three different methods of extraction to determine the relative efficiency of each lysis method with respect to Jak2 protein yield and catalytic activity. We found that lysis methods utilizing detergents increased the efficiency of protein extraction about 3-fold when compared to a method lacking detergent. However, with respect to catalytic activity, Jak2 isolated from cells using detergent-containing lysis buffers had significantly less catalytic activity than when compared to the method that was detergent free. Expression was then scaled up and Jak2 protein was purified via a one step immunoaffinity purification scheme using both the detergent-free and a modified detergent-containing method of extraction that maintained catalytic activity. In vitro kinase assays demonstrated that the purified product was highly catalytic as measured by its ability to tyrosine phosphorylate Stat1. Collectively, the results show that (1) Jak2 can be expressed at very high levels in mammalian cells, (2) it can be purified to homogeneity via a single step purification scheme, and (3) the purified product is biologically active. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 19 条
[1]   Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT(1) receptor [J].
Ali, MS ;
Sayeski, PP ;
Dirksen, LB ;
Hayzer, DJ ;
Marrero, MB ;
Bernstein, KE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23382-23388
[2]   CHARACTERIZATION OF ACTIVE AND INACTIVE FORMS OF THE JAK2 PROTEIN-TYROSINE KINASE PRODUCED VIA THE BACULOVIRUS EXPRESSION VECTOR SYSTEM [J].
DUHE, RJ ;
FARRAR, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (39) :23084-23089
[3]   Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein [J].
Duhé, RJ ;
Clark, EA ;
Farrar, WL .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2002, 236 (1-2) :23-35
[4]  
EARL, 1998, CURRENT PROTOCOLS MO
[5]   STRUCTURE AND STABILITY OF MESSENGER-RNA SYNTHESIZED BY VACCINIA VIRUS-ENCODED BACTERIOPHAGE T7 RNA-POLYMERASE IN MAMMALIAN-CELLS - IMPORTANCE OF THE 5' UNTRANSLATED LEADER [J].
FUERST, TR ;
MOSS, B .
JOURNAL OF MOLECULAR BIOLOGY, 1989, 206 (02) :333-348
[6]   Signaling by Type I and II cytokine receptors: ten years after [J].
Gadina, M ;
Hilton, D ;
Johnston, JA ;
Morinobu, A ;
Lighvani, A ;
Zhou, YJ ;
Visconti, R ;
O'Shea, JJ .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (03) :363-373
[7]   Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor [J].
Meydan, N ;
Grunberger, T ;
Dadi, H ;
Shahar, M ;
Arpaia, E ;
Lapidot, Z ;
Leeder, JS ;
Freedman, M ;
Cohen, A ;
Gazit, A ;
Levitzki, A ;
Roifman, CM .
NATURE, 1996, 379 (6566) :645-648
[8]   VACCINIA VIRUS - A TOOL FOR RESEARCH AND VACCINE DEVELOPMENT [J].
MOSS, B .
SCIENCE, 1991, 252 (5013) :1662-1667
[9]   Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart [J].
Pan, J ;
Fukuda, K ;
Kodama, H ;
Makino, S ;
Takahashi, T ;
Sano, M ;
Hori, S ;
Ogawa, S .
CIRCULATION RESEARCH, 1997, 81 (04) :611-617
[10]   Jak2 is essential for signaling through a variety of cytokine receptors [J].
Parganas, E ;
Wang, D ;
Stravopodis, D ;
Topham, DJ ;
Marine, JC ;
Teglund, S ;
Vanin, EF ;
Bodner, S ;
Colamonici, OR ;
van Deursen, JM ;
Grosveld, G ;
Ihle, JN .
CELL, 1998, 93 (03) :385-395